Cutera (NASDAQ:CUTR) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Performance

CUTR stock opened at $0.31 on Friday. Cutera has a 52 week low of $0.28 and a 52 week high of $3.00. The firm’s fifty day moving average is $0.43 and its 200 day moving average is $0.53. The firm has a market cap of $6.35 million, a P/E ratio of -0.05 and a beta of 1.32.

Institutional Investors Weigh In On Cutera

An institutional investor recently raised its position in Cutera stock. Geode Capital Management LLC boosted its position in Cutera, Inc. (NASDAQ:CUTR) by 25.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 248,257 shares of the medical device company’s stock after acquiring an additional 50,046 shares during the period. Geode Capital Management LLC owned 1.23% of Cutera worth $88,000 at the end of the most recent reporting period. 90.70% of the stock is owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.